Guan Bugao, Li Hongbo, Yao Jian, Guo Jinbao, Yu Fei, Li Guangrun, Wan Benhai, Ma Jun, Huang Desong, Sun Lu, Chen Yan
Department of General Surgery, Jinhu People's Hospital, Huai'an, China.
The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an Second People's Hospital, Huai'an, China.
Environ Toxicol. 2023 Jan;38(1):172-184. doi: 10.1002/tox.23675. Epub 2022 Nov 8.
Infiltration of tumor-associated macrophages (TAMs) can promote tumorigenesis and development. C-C motif chemokine ligand 3 (CCL3) was reported to be derived from TAMs and tumor cells and facilitate the progression of several cancers. Nevertheless, whether CCL3 can be derived from TAMs and tumor cells of colon adenocarcinoma (COAD) is unclarified.
Peripheral blood monocytes-derived macrophages were polarized by the conditioned medium from COAD cells to establish TAM-like macrophages (TAM1/2). RT-qPCR and western blotting were used for detection of expression levels of CCL3 and its receptors C-C motif chemokine receptor 1 (CCR1) and CCR5 in TAM1/2 and COAD cells. Immunofluorescence staining was utilized for evaluating CCL3, CD163 and CCR5 expression. The Akt signaling pathway-associated protein levels were measured by western blotting. Transwell assays were used for assessing cell migration and invasiveness.
CCL3 displayed a high level in TAMs and cancer cells of COAD. CCL3 activated the Akt signaling pathway by binding to CCR5. CCL3-CCR5 axis facilitated COAD cell migration and invasiveness by activating the Akt signaling. CCL3 derived from both TAMs and cancer cells contributed to the malignant behaviors of COAD cells. High expression of CCL3/CCR5 was closely associated with poor prognoses of COAD patients.
CCL3-CCR5 interaction promotes cell migration and invasiveness, and functions as a prognostic biomarker for COAD.
肿瘤相关巨噬细胞(TAM)浸润可促进肿瘤发生和发展。据报道,C-C基序趋化因子配体3(CCL3)来源于TAM和肿瘤细胞,并促进多种癌症的进展。然而,CCL3是否可来源于结肠腺癌(COAD)的TAM和肿瘤细胞尚不清楚。
用COAD细胞的条件培养基将外周血单核细胞来源的巨噬细胞极化,以建立TAM样巨噬细胞(TAM1/2)。采用RT-qPCR和蛋白质印迹法检测TAM1/2和COAD细胞中CCL3及其受体C-C基序趋化因子受体1(CCR1)和CCR5的表达水平。利用免疫荧光染色评估CCL3、CD163和CCR5的表达。通过蛋白质印迹法检测Akt信号通路相关蛋白水平。采用Transwell实验评估细胞迁移和侵袭能力。
CCL3在COAD的TAM和癌细胞中呈高水平表达。CCL3通过与CCR5结合激活Akt信号通路。CCL3-CCR5轴通过激活Akt信号促进COAD细胞迁移和侵袭。来源于TAM和癌细胞的CCL3均促成了COAD细胞的恶性行为。CCL3/CCR5的高表达与COAD患者的不良预后密切相关。
CCL3-CCR5相互作用促进细胞迁移和侵袭,并作为COAD的预后生物标志物发挥作用。